Explore
Validate
Learn10927-1-AP
antibody from Proteintech Group
Targeting: CXCL13
ANGIE, ANGIE2, BCA-1, BLC, BLR1L, SCYB13
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [11]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 10927-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#10927-1-AP, RRID:AB_2086050
- Product name
- CXCL13/BCA1 antibody
- Antibody type
- Polyclonal
- Description
- CXCL13/BCA1 antibody (Cat. #10927-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references A Standardized Analysis of Tertiary Lymphoid Structures in Human Melanoma: Disease Progression- and Tumor Site-Associated Changes With Germinal Center Alteration.
Single-Cell RNA-seq Reveals Characteristics of Malignant Cells and Immune Microenvironment in Subcutaneous Panniculitis-Like T-Cell Lymphoma.
MIN score predicts primary response to infliximab/adalimumab and vedolizumab therapy in patients with inflammatory bowel diseases.
Defined lifestyle and germline factors predispose Asian populations to gastric cancer.
Immune profiling reveals prognostic genes in high-grade serous ovarian cancer.
B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma.
Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis.
MicroRNA‑186‑5p mediates osteoblastic differentiation and cell viability by targeting CXCL13 in non‑traumatic osteonecrosis.
The role of high serum CXCL13 level in Waldenström macroglobulinemia.
Villitis of unknown etiology is associated with a distinct pattern of chemokine up-regulation in the feto-maternal and placental compartments: implications for conjoint maternal allograft rejection and maternal anti-fetal graft-versus-host disease.
A role for CXCL13 (BCA-1) in pregnancy and intra-amniotic infection/inflammation.
Werner F, Wagner C, Simon M, Glatz K, Mertz KD, Läubli H, Griss J, Wagner SN
Frontiers in immunology 2021;12:675146
Frontiers in immunology 2021;12:675146
Single-Cell RNA-seq Reveals Characteristics of Malignant Cells and Immune Microenvironment in Subcutaneous Panniculitis-Like T-Cell Lymphoma.
Li Z, Wang H, Dong R, Man J, Sun L, Qian X, Zhu X, Cao P, Yu Y, Le J, Fu Y, Wang P, Jiang W, Shen C, Ma Y, Chen L, Xu Y, Shi J, Zhang H, Qian M, Zhai X
Frontiers in oncology 2021;11:611580
Frontiers in oncology 2021;11:611580
MIN score predicts primary response to infliximab/adalimumab and vedolizumab therapy in patients with inflammatory bowel diseases.
Shi Y, He W, Zhong M, Yu M
Genomics 2021 Jul;113(4):1988-1998
Genomics 2021 Jul;113(4):1988-1998
Defined lifestyle and germline factors predispose Asian populations to gastric cancer.
Suzuki A, Katoh H, Komura D, Kakiuchi M, Tagashira A, Yamamoto S, Tatsuno K, Ueda H, Nagae G, Fukuda S, Umeda T, Totoki Y, Abe H, Ushiku T, Matsuura T, Sakai E, Ohshima T, Nomura S, Seto Y, Shibata T, Rino Y, Nakajima A, Fukayama M, Ishikawa S, Aburatani H
Science advances 2020 May;6(19):eaav9778
Science advances 2020 May;6(19):eaav9778
Immune profiling reveals prognostic genes in high-grade serous ovarian cancer.
Wu Y, Xia L, Zhao P, Deng Y, Guo Q, Zhu J, Chen X, Ju X, Wu X
Aging 2020 Jun 16;12(12):11398-11415
Aging 2020 Jun 16;12(12):11398-11415
B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma.
Griss J, Bauer W, Wagner C, Simon M, Chen M, Grabmeier-Pfistershammer K, Maurer-Granofszky M, Roka F, Penz T, Bock C, Zhang G, Herlyn M, Glatz K, Läubli H, Mertz KD, Petzelbauer P, Wiesner T, Hartl M, Pickl WF, Somasundaram R, Steinberger P, Wagner SN
Nature communications 2019 Sep 13;10(1):4186
Nature communications 2019 Sep 13;10(1):4186
Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis.
Xu T, Ruan H, Song Z, Cao Q, Wang K, Bao L, Liu D, Tong J, Yang H, Chen K, Zhang X
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2019 Oct;118:109264
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2019 Oct;118:109264
MicroRNA‑186‑5p mediates osteoblastic differentiation and cell viability by targeting CXCL13 in non‑traumatic osteonecrosis.
Xu W, Li J, Tian H, Wang R, Feng Y, Tang J, Jia J
Molecular medicine reports 2019 Nov;20(5):4594-4602
Molecular medicine reports 2019 Nov;20(5):4594-4602
The role of high serum CXCL13 level in Waldenström macroglobulinemia.
Wu YY, Cai H, Zhao AL, Zhang L, Zhou DB, Cao XX, Li J
Leukemia research 2019 Jun;81:50-55
Leukemia research 2019 Jun;81:50-55
Villitis of unknown etiology is associated with a distinct pattern of chemokine up-regulation in the feto-maternal and placental compartments: implications for conjoint maternal allograft rejection and maternal anti-fetal graft-versus-host disease.
Kim MJ, Romero R, Kim CJ, Tarca AL, Chhauy S, LaJeunesse C, Lee DC, Draghici S, Gotsch F, Kusanovic JP, Hassan SS, Kim JS
Journal of immunology (Baltimore, Md. : 1950) 2009 Mar 15;182(6):3919-27
Journal of immunology (Baltimore, Md. : 1950) 2009 Mar 15;182(6):3919-27
A role for CXCL13 (BCA-1) in pregnancy and intra-amniotic infection/inflammation.
Nhan-Chang CL, Romero R, Kusanovic JP, Gotsch F, Edwin SS, Erez O, Mittal P, Kim CJ, Kim MJ, Espinoza J, Friel LA, Vaisbuch E, Than NG, Mazaki-Tovi S, Hassan SS
The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2008 Nov;21(11):763-75
The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2008 Nov;21(11):763-75
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- human placenta tissue were subjected to SDS PAGE followed by western blot with 10927-1-AP(CXCL13 antibody) at dilution of 1:200
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The CXCL13 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human CXCL13. This antibody recognizes human antigen. The CXCL13 antibody has been validated for the following applications: ELISA, WB, IHC analysis.
